30
Participants
Start Date
October 31, 2014
Primary Completion Date
January 31, 2018
Study Completion Date
January 31, 2018
Oxcarbazepine
Oxcarbazepine 150mg tablet, over encapsulated and back-filled with Microcrystalline Cellulose/Magnesium Stearate 1%.
Placebo
Placebo in a matched capsule containing Microcrystalline Cellulose/Magnesium Stearate 1%.
Barts Health NHS Trust, London
Collaborators (1)
National Multiple Sclerosis Society
OTHER
Novartis Pharmaceuticals
INDUSTRY
Barts & The London NHS Trust
OTHER
University College, London
OTHER
Royal Free Hospital NHS Foundation Trust
OTHER
Mid and South Essex NHS Foundation Trust
OTHER
St George's Healthcare NHS Trust
OTHER
Barnet and Chase Farm Hospitals NHS Trust
OTHER
Queen Mary University of London
OTHER